Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer

Yoshihiko Maehara, Tatsuo Oshiro, Hisao Ohiwa, Shinichi Tomisaki, Yoshihisa Sakaguchi, Tetsuya Kusumoto, Shinji Ohno, Hideo Baba, Yuji Ichiyoshi, Keizo Sugimachi

Research output: Contribution to journalArticle

Abstract

To determine independent risk factors for recurrenceof gastric cancer, we carried out multivariate analysis using stepwise logistic regression, the multivariate analysis revealed that the presence of serosal invasion, and Borrmann type 4 cancer were the greatest risk factors for peritoneal dissemination. The presence of lymph node metastasis and vessel invasion were the greatest-risk factors for a haematogenous recurrence. We evaluated the expression of the c-erbB-2 protein and the abnormal p53 protein in gastric cancer, using monoclonal antibodies mAb 1 and PAb240, respectively. Patients with positive staining for c-erbB-2 protein had higher recurrence rates, including lymph node metastasis, hepatic metastasis and peritoneal dissemination. Tumors stained positively forp53 metastasized to lymph nodes more frequently thanthose with negative staining. The succinate dehydrogenase inhibition (SDI) test was used to determine chemosensitivity. Lymph node metastasis was more sensitive to anticancer drugs than the corresponding primary lesions, while hepatic metastasis was less sensitive than the corresponding primary lesion. The concomitant administration of OK-432 and anticancer drugfor patients with gastric cancer invading the serosawas significantly useful treatment for the prevention of peritoneal recurrence. These data show that “type-oriented chemotherapy ” is essential for patients with high risk factors for recurrence of gastric cancer based on individual biological characteristics.

Original languageEnglish
Pages (from-to)2289-2292
Number of pages4
Journalthe japanese journal of gastroenterological surgery
Volume27
Issue number10
DOIs
Publication statusPublished - Jan 1 1994

Fingerprint

Biological Therapy
Certification
Stomach Neoplasms
Neoplasm Metastasis
Recurrence
Lymph Nodes
ErbB-2 Receptor
Multivariate Analysis
Picibanil
Negative Staining
Succinate Dehydrogenase
Liver
Neoplasms
Logistic Models
Monoclonal Antibodies
Regression Analysis
Staining and Labeling
Drug Therapy
Pharmaceutical Preparations
Proteins

All Science Journal Classification (ASJC) codes

  • Surgery
  • Gastroenterology

Cite this

Maehara, Y., Oshiro, T., Ohiwa, H., Tomisaki, S., Sakaguchi, Y., Kusumoto, T., ... Sugimachi, K. (1994). Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer. the japanese journal of gastroenterological surgery, 27(10), 2289-2292. https://doi.org/10.5833/jjgs.27.2289

Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer. / Maehara, Yoshihiko; Oshiro, Tatsuo; Ohiwa, Hisao; Tomisaki, Shinichi; Sakaguchi, Yoshihisa; Kusumoto, Tetsuya; Ohno, Shinji; Baba, Hideo; Ichiyoshi, Yuji; Sugimachi, Keizo.

In: the japanese journal of gastroenterological surgery, Vol. 27, No. 10, 01.01.1994, p. 2289-2292.

Research output: Contribution to journalArticle

Maehara, Y, Oshiro, T, Ohiwa, H, Tomisaki, S, Sakaguchi, Y, Kusumoto, T, Ohno, S, Baba, H, Ichiyoshi, Y & Sugimachi, K 1994, 'Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer', the japanese journal of gastroenterological surgery, vol. 27, no. 10, pp. 2289-2292. https://doi.org/10.5833/jjgs.27.2289
Maehara, Yoshihiko ; Oshiro, Tatsuo ; Ohiwa, Hisao ; Tomisaki, Shinichi ; Sakaguchi, Yoshihisa ; Kusumoto, Tetsuya ; Ohno, Shinji ; Baba, Hideo ; Ichiyoshi, Yuji ; Sugimachi, Keizo. / Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer. In: the japanese journal of gastroenterological surgery. 1994 ; Vol. 27, No. 10. pp. 2289-2292.
@article{4f9665f3b74746be94f5ac5443d55ee5,
title = "Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer",
abstract = "To determine independent risk factors for recurrenceof gastric cancer, we carried out multivariate analysis using stepwise logistic regression, the multivariate analysis revealed that the presence of serosal invasion, and Borrmann type 4 cancer were the greatest risk factors for peritoneal dissemination. The presence of lymph node metastasis and vessel invasion were the greatest-risk factors for a haematogenous recurrence. We evaluated the expression of the c-erbB-2 protein and the abnormal p53 protein in gastric cancer, using monoclonal antibodies mAb 1 and PAb240, respectively. Patients with positive staining for c-erbB-2 protein had higher recurrence rates, including lymph node metastasis, hepatic metastasis and peritoneal dissemination. Tumors stained positively forp53 metastasized to lymph nodes more frequently thanthose with negative staining. The succinate dehydrogenase inhibition (SDI) test was used to determine chemosensitivity. Lymph node metastasis was more sensitive to anticancer drugs than the corresponding primary lesions, while hepatic metastasis was less sensitive than the corresponding primary lesion. The concomitant administration of OK-432 and anticancer drugfor patients with gastric cancer invading the serosawas significantly useful treatment for the prevention of peritoneal recurrence. These data show that “type-oriented chemotherapy ” is essential for patients with high risk factors for recurrence of gastric cancer based on individual biological characteristics.",
author = "Yoshihiko Maehara and Tatsuo Oshiro and Hisao Ohiwa and Shinichi Tomisaki and Yoshihisa Sakaguchi and Tetsuya Kusumoto and Shinji Ohno and Hideo Baba and Yuji Ichiyoshi and Keizo Sugimachi",
year = "1994",
month = "1",
day = "1",
doi = "10.5833/jjgs.27.2289",
language = "English",
volume = "27",
pages = "2289--2292",
journal = "Japanese Journal of Gastroenterological Surgery",
issn = "0386-9768",
publisher = "Japanese Society of Gastroenterological Surgery",
number = "10",

}

TY - JOUR

T1 - Certification of Biological Character and Therapy in Regard to the Recurrence of the Gastric Cancer

AU - Maehara, Yoshihiko

AU - Oshiro, Tatsuo

AU - Ohiwa, Hisao

AU - Tomisaki, Shinichi

AU - Sakaguchi, Yoshihisa

AU - Kusumoto, Tetsuya

AU - Ohno, Shinji

AU - Baba, Hideo

AU - Ichiyoshi, Yuji

AU - Sugimachi, Keizo

PY - 1994/1/1

Y1 - 1994/1/1

N2 - To determine independent risk factors for recurrenceof gastric cancer, we carried out multivariate analysis using stepwise logistic regression, the multivariate analysis revealed that the presence of serosal invasion, and Borrmann type 4 cancer were the greatest risk factors for peritoneal dissemination. The presence of lymph node metastasis and vessel invasion were the greatest-risk factors for a haematogenous recurrence. We evaluated the expression of the c-erbB-2 protein and the abnormal p53 protein in gastric cancer, using monoclonal antibodies mAb 1 and PAb240, respectively. Patients with positive staining for c-erbB-2 protein had higher recurrence rates, including lymph node metastasis, hepatic metastasis and peritoneal dissemination. Tumors stained positively forp53 metastasized to lymph nodes more frequently thanthose with negative staining. The succinate dehydrogenase inhibition (SDI) test was used to determine chemosensitivity. Lymph node metastasis was more sensitive to anticancer drugs than the corresponding primary lesions, while hepatic metastasis was less sensitive than the corresponding primary lesion. The concomitant administration of OK-432 and anticancer drugfor patients with gastric cancer invading the serosawas significantly useful treatment for the prevention of peritoneal recurrence. These data show that “type-oriented chemotherapy ” is essential for patients with high risk factors for recurrence of gastric cancer based on individual biological characteristics.

AB - To determine independent risk factors for recurrenceof gastric cancer, we carried out multivariate analysis using stepwise logistic regression, the multivariate analysis revealed that the presence of serosal invasion, and Borrmann type 4 cancer were the greatest risk factors for peritoneal dissemination. The presence of lymph node metastasis and vessel invasion were the greatest-risk factors for a haematogenous recurrence. We evaluated the expression of the c-erbB-2 protein and the abnormal p53 protein in gastric cancer, using monoclonal antibodies mAb 1 and PAb240, respectively. Patients with positive staining for c-erbB-2 protein had higher recurrence rates, including lymph node metastasis, hepatic metastasis and peritoneal dissemination. Tumors stained positively forp53 metastasized to lymph nodes more frequently thanthose with negative staining. The succinate dehydrogenase inhibition (SDI) test was used to determine chemosensitivity. Lymph node metastasis was more sensitive to anticancer drugs than the corresponding primary lesions, while hepatic metastasis was less sensitive than the corresponding primary lesion. The concomitant administration of OK-432 and anticancer drugfor patients with gastric cancer invading the serosawas significantly useful treatment for the prevention of peritoneal recurrence. These data show that “type-oriented chemotherapy ” is essential for patients with high risk factors for recurrence of gastric cancer based on individual biological characteristics.

UR - http://www.scopus.com/inward/record.url?scp=85008094213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008094213&partnerID=8YFLogxK

U2 - 10.5833/jjgs.27.2289

DO - 10.5833/jjgs.27.2289

M3 - Article

AN - SCOPUS:85008094213

VL - 27

SP - 2289

EP - 2292

JO - Japanese Journal of Gastroenterological Surgery

JF - Japanese Journal of Gastroenterological Surgery

SN - 0386-9768

IS - 10

ER -